ARTICLE | Clinical News
Olinvo: Ph III APOLLO-2 data
February 24, 2017 7:01 PM UTC
Top-line data from the double-blind, U.S. Phase III APOLLO-2 trial in 401 patients with moderate to severe acute pain following abdominoplasty showed that 0.1, 0.35 and 0.5 mg IV Olinvo as needed each...
BCIQ Company Profiles
BCIQ Target Profiles